US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Protalix BioTherapeutics

2.89

-0.0200-0.69%

Post-market: 2.87-0.0200-0.69%19:36 EST

Volume:2.56M

Turnover:7.29M

Market Cap:232.42M

PE:41.84

High:2.93

Open:2.89

Low:2.78

Close:2.91

52wk High:3.10

52wk Low:1.32

Shares:80.42M

Float Shares:60.76M

Volume Ratio:0.96

T/O Rate:4.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.0691

EPS(LYR):0.0367

ROE:12.64%

ROA:5.53%

PB:4.39

PE(LYR):78.85

Loading ...

Overview Company News Filings

Protalix BioTherapeutics Shares Up After CHMP Issued Positive Opinion on New Dosing Regimen for Fabry Disease Treatment

Protalix Fabry Disease Treatment Recommended for Approval by EMA Committee

MT Newswires Live

CHMP Recommends Approval of New Elfabrio Dosing Regimen for Protalix BioTherapeutics

PLUXEE N.V. (PLX) Receives a Buy from Kepler Capital

Protalix BioTherapeutics Projects Profitable Growth Anchored by Elfabrio Sales in 2026

Protalix BioTherapeutics CEO Dror Bashan Acquires Common Shares

Protalix BioTherapeutics and Secarna Pharmaceuticals partner to develop rare kidney disease therapies

Protalix BioTherapeutics Is Maintained at Buy by HC Wainwright & Co.

Protalix price target lowered to $12 from $15 at H.C. Wainwright

Protalix BioTherapeutics Q3 EPS USD 0.03

Chiesi Global Rare Diseases Seeks Ema Chmp Re-Exam Of Negative View On Elfabrio 2 Mg/Kg Q4w Dosing

Bernstein Remains a Hold on PLUXEE N.V. (PLX)

Kepler Capital Remains a Buy on PLUXEE N.V. (PLX)

Protalix BioTherapeutics showcases pipeline advances and growth strategy for rare disease treatments

Barclays Keeps Their Hold Rating on PLUXEE N.V. (PLX)

Protalix BioTherapeutics’ Earnings Call Highlights Growth and Challenges

Protalix BioTherapeutics Q3 EPS USD 0.03

Protalix BioTherapeutics Q3 EPS $0.03 Misses $0.06 Estimate, Sales $17.673M Miss $17.866M Estimate

Press Release: Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results

Protalix BioTherapeutics Inc. to Report Third Quarter 2025 Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PLX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PLX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLX\",,,,,undefined,":{"symbol":"PLX","market":"US","secType":"STK","nameCN":"Protalix BioTherapeutics","latestPrice":2.89,"timestamp":1770411600000,"preClose":2.91,"halted":0,"volume":2559570,"hourTrading":{"tag":"盘后","latestPrice":2.87,"preClose":2.89,"latestTime":"19:36 EST","volume":24742,"amount":71359.827,"timestamp":1770424583505,"change":-0.02,"changeRate":-0.00692,"amplitude":0.030692},"delay":0,"changeRate":-0.006872852233676982,"floatShares":60755281,"shares":80421181,"eps":0.069071,"marketStatus":"Market Closed","change":-0.02,"latestTime":"02-06 16:00:00 EST","open":2.89,"high":2.93,"low":2.78,"amount":7285865.148744,"amplitude":0.051546,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.069071,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":829022400000,"exchange":"AMEX","adjPreClose":2.91,"preHourTrading":{"tag":"盘前","latestPrice":2.9,"preClose":2.91,"latestTime":"09:25 EST","volume":13552,"amount":38790.323264,"timestamp":1770387921075,"change":-0.01,"changeRate":-0.003436,"amplitude":0.024055},"postHourTrading":{"tag":"盘后","latestPrice":2.87,"preClose":2.89,"latestTime":"19:36 EST","volume":24742,"amount":71359.827,"timestamp":1770424583505,"change":-0.02,"changeRate":-0.00692,"amplitude":0.030692},"volumeRatio":0.957318,"impliedVol":1.193,"impliedVolPercentile":0.753},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLX\",,,,,undefined,":{"symbol":"PLX","floatShares":60755281,"roa":"5.53%","roe":"12.64%","lyrEps":0.036653,"volumeRatio":0.957318,"shares":80421181,"dividePrice":0,"high":2.93,"amplitude":0.051546,"preClose":2.91,"low":2.78,"week52Low":1.32,"pbRate":"4.39","psRate":"3.76","week52High":3.1,"institutionHeld":0.3055,"latestPrice":2.89,"eps":0.069071,"divideRate":0,"volume":2559570,"delay":0,"ttmEps":0.069071,"open":2.89,"prevYearClose":1.8,"prevWeekClose":2.34,"prevMonthClose":2.34,"prevQuarterClose":1.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PLX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"PLX","fiscalQuarterEnding":"2025/09","expectedEps":0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":0.03},{"market":"US","date":"2025-08-14","symbol":"PLX","fiscalQuarterEnding":"2025/06","expectedEps":0.03,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":0},{"market":"US","date":"2025-05-09","symbol":"PLX","fiscalQuarterEnding":"2025/03","expectedEps":0.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2025-03-17","symbol":"PLX","fiscalQuarterEnding":"2024/12","expectedEps":0.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"pre","actualEps":0.09},{"market":"US","date":"2024-11-14","symbol":"PLX","fiscalQuarterEnding":"2024/09","expectedEps":0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"pre","actualEps":0.03}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PLX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PLX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1738645200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PLX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PLX","date":"2026-02-05","current":41.841004,"percent":0.969081,"low":-43.274752,"twenty":-7.664219,"median":-2.25376,"eighty":14.732722,"high":81.705333,"avg":3.630023,"sd":19.521839,"marketCap":233221424},"quantilePoints":[{"date":"2021-02-12","current":-32.70229,"twenty":-5.396455,"median":-2.159816,"eighty":-1.286168,"marketCap":216783482},{"date":"2021-02-19","current":-34.103817,"twenty":-5.467461,"median":-2.159816,"eighty":-1.286168,"marketCap":226074202},{"date":"2021-02-26","current":-33.545915,"twenty":-5.52745,"median":-2.159816,"eighty":-1.286168,"marketCap":222375871},{"date":"2021-03-05","current":-28.68518,"twenty":-5.574564,"median":-2.158792,"eighty":-1.286095,"marketCap":190154061},{"date":"2021-03-12","current":-33.20361,"twenty":-5.648785,"median":-2.158792,"eighty":-1.286095,"marketCap":220106730},{"date":"2021-03-19","current":-34.915136,"twenty":-5.812013,"median":-2.158792,"eighty":-1.286095,"marketCap":231452438},{"date":"2021-03-26","current":-33.066688,"twenty":-5.93244,"median":-2.159816,"eighty":-1.286168,"marketCap":219199073},{"date":"2021-04-01","current":-31.238527,"twenty":-6.011792,"median":-2.159816,"eighty":-1.286168,"marketCap":203768911},{"date":"2021-04-09","current":-36.595691,"twenty":-6.161232,"median":-2.158792,"eighty":-1.286095,"marketCap":238713691},{"date":"2021-04-16","current":-43.135605,"twenty":-6.301781,"median":-2.158792,"eighty":-1.286095,"marketCap":281373552},{"date":"2021-04-23","current":-43.274752,"twenty":-6.484124,"median":-2.158792,"eighty":-1.286095,"marketCap":282281208},{"date":"2021-04-30","current":-23.307141,"twenty":-6.640471,"median":-2.159816,"eighty":-1.286168,"marketCap":152032483},{"date":"2021-05-07","current":-21.150361,"twenty":-6.746429,"median":-2.159816,"eighty":-1.286168,"marketCap":137963806},{"date":"2021-05-14","current":-9.099814,"twenty":-6.956439,"median":-2.159816,"eighty":-1.286168,"marketCap":124348956},{"date":"2021-05-21","current":-9.664401,"twenty":-7.610873,"median":-2.159816,"eighty":-1.286168,"marketCap":132064038},{"date":"2021-05-28","current":-10.096144,"twenty":-9.073245,"median":-2.159816,"eighty":-1.286168,"marketCap":137963806},{"date":"2021-06-04","current":-7.107154,"twenty":-9.166236,"median":-2.159816,"eighty":-1.286168,"marketCap":97119258},{"date":"2021-06-11","current":-7.206787,"twenty":-9.166236,"median":-2.159816,"eighty":-1.286168,"marketCap":98480743},{"date":"2021-06-18","current":-6.6422,"twenty":-9.166236,"median":-2.159816,"eighty":-1.286168,"marketCap":90765662},{"date":"2021-06-25","current":-6.608989,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":90311833},{"date":"2021-07-02","current":-5.97798,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":81689095},{"date":"2021-07-09","current":-5.745503,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":78512297},{"date":"2021-07-16","current":-5.247338,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":71704872},{"date":"2021-07-23","current":-5.214127,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":71251044},{"date":"2021-07-30","current":-5.014861,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":68528074},{"date":"2021-08-06","current":-4.98165,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":68074246},{"date":"2021-08-13","current":-4.450274,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":60812993},{"date":"2021-08-20","current":-2.941121,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":61045906},{"date":"2021-08-27","current":-3.511786,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":72890635},{"date":"2021-09-03","current":-3.533735,"twenty":-9.093172,"median":-2.165862,"eighty":-1.286241,"marketCap":73346201},{"date":"2021-09-10","current":-3.2923,"twenty":-9.093172,"median":-2.168414,"eighty":-1.286241,"marketCap":68334970},{"date":"2021-09-17","current":-3.072813,"twenty":-9.093172,"median":-2.169861,"eighty":-1.286241,"marketCap":63779305},{"date":"2021-09-24","current":-2.875275,"twenty":-9.093172,"median":-2.173457,"eighty":-1.286241,"marketCap":59679207},{"date":"2021-10-01","current":-2.743583,"twenty":-9.093172,"median":-2.185224,"eighty":-1.286241,"marketCap":56945808},{"date":"2021-10-08","current":-2.919172,"twenty":-9.08653,"median":-2.194729,"eighty":-1.286241,"marketCap":60590340},{"date":"2021-10-15","current":-2.699686,"twenty":-9.08653,"median":-2.198569,"eighty":-1.286241,"marketCap":56034675},{"date":"2021-10-22","current":-2.546045,"twenty":-9.08653,"median":-2.208245,"eighty":-1.286241,"marketCap":52845710},{"date":"2021-10-29","current":-2.480199,"twenty":-9.08653,"median":-2.213276,"eighty":-1.286241,"marketCap":51479011},{"date":"2021-11-05","current":-2.436302,"twenty":-9.08653,"median":-2.224699,"eighty":-1.286241,"marketCap":50567878},{"date":"2021-11-12","current":-2.502148,"twenty":-9.08653,"median":-2.237881,"eighty":-1.286241,"marketCap":51934577},{"date":"2021-11-19","current":-2.175919,"twenty":-9.08653,"median":-2.240695,"eighty":-1.286241,"marketCap":44645514},{"date":"2021-11-26","current":-2.198123,"twenty":-9.08653,"median":-2.240695,"eighty":-1.286241,"marketCap":45101080},{"date":"2021-12-03","current":-1.806013,"twenty":-9.08653,"median":-2.233869,"eighty":-1.286241,"marketCap":37055776},{"date":"2021-12-10","current":-2.038925,"twenty":-9.079887,"median":-2.232086,"eighty":-1.286241,"marketCap":41834668},{"date":"2021-12-17","current":-1.940121,"twenty":-9.079887,"median":-2.232086,"eighty":-1.286241,"marketCap":39807398},{"date":"2021-12-23","current":-2.10931,"twenty":-9.079887,"median":-2.232086,"eighty":-1.286241,"marketCap":43278814},{"date":"2021-12-31","current":-1.846645,"twenty":-9.079887,"median":-2.228368,"eighty":-1.286241,"marketCap":37889463},{"date":"2022-01-07","current":-1.90948,"twenty":-9.073245,"median":-2.222793,"eighty":-1.286241,"marketCap":39178716},{"date":"2022-01-14","current":-1.909036,"twenty":-9.073245,"median":-2.219151,"eighty":-1.286241,"marketCap":39169605},{"date":"2022-01-21","current":-1.809011,"twenty":-9.073245,"median":-2.213239,"eighty":-1.286241,"marketCap":37117278},{"date":"2022-01-28","current":-1.800151,"twenty":-9.073245,"median":-2.199659,"eighty":-1.286241,"marketCap":36935507},{"date":"2022-02-04","current":-2.286936,"twenty":-9.073245,"median":-2.19473,"eighty":-1.286241,"marketCap":46923346},{"date":"2022-02-11","current":-2.053801,"twenty":-9.073245,"median":-2.192317,"eighty":-1.286241,"marketCap":42139898},{"date":"2022-02-18","current":-1.900155,"twenty":-9.073245,"median":-2.182859,"eighty":-1.286241,"marketCap":38987378},{"date":"2022-02-25","current":-1.845979,"twenty":-9.073245,"median":-2.171729,"eighty":-1.286241,"marketCap":37875796},{"date":"2022-03-04","current":-1.953887,"twenty":-9.073245,"median":-2.164775,"eighty":-1.286241,"marketCap":40089849},{"date":"2022-03-11","current":-1.931683,"twenty":-9.073245,"median":-2.149114,"eighty":-1.286241,"marketCap":39634282},{"date":"2022-03-18","current":-2.331342,"twenty":-9.073245,"median":-2.134081,"eighty":-1.286241,"marketCap":47834479},{"date":"2022-03-25","current":-2.58668,"twenty":-9.073245,"median":-2.134081,"eighty":-1.286241,"marketCap":53073493},{"date":"2022-04-01","current":-1.763177,"twenty":-9.073245,"median":-2.127387,"eighty":-1.286241,"marketCap":48631935},{"date":"2022-04-08","current":-2.518824,"twenty":-9.073245,"median":-2.127387,"eighty":-1.286241,"marketCap":69474193},{"date":"2022-04-14","current":-2.199773,"twenty":-9.073245,"median":-2.127387,"eighty":-1.286241,"marketCap":60674128},{"date":"2022-04-22","current":-2.000411,"twenty":-9.073245,"median":-2.122964,"eighty":-1.286241,"marketCap":55175340},{"date":"2022-04-29","current":-1.950023,"twenty":-9.073245,"median":-2.109577,"eighty":-1.286241,"marketCap":53785525},{"date":"2022-05-06","current":-1.907996,"twenty":-9.073245,"median":-2.106167,"eighty":-1.286241,"marketCap":52626354},{"date":"2022-05-13","current":-1.781917,"twenty":-9.073245,"median":-2.101634,"eighty":-1.296523,"marketCap":49148841},{"date":"2022-05-20","current":-2.19949,"twenty":-9.073245,"median":-2.104124,"eighty":-1.305734,"marketCap":53652162},{"date":"2022-05-27","current":-2.19949,"twenty":-9.073245,"median":-2.108744,"eighty":-1.316067,"marketCap":53652162},{"date":"2022-06-03","current":-2.392428,"twenty":-9.073245,"median":-2.111908,"eighty":-1.325755,"marketCap":58358492},{"date":"2022-06-10","current":-2.160903,"twenty":-9.073245,"median":-2.122315,"eighty":-1.336668,"marketCap":52710896},{"date":"2022-06-17","current":-2.103021,"twenty":-9.073245,"median":-2.122315,"eighty":-1.340638,"marketCap":51298997},{"date":"2022-06-24","current":-2.103021,"twenty":-9.079887,"median":-2.122315,"eighty":-1.345105,"marketCap":51298997},{"date":"2022-07-01","current":-2.093374,"twenty":-9.079887,"median":-2.123693,"eighty":-1.358968,"marketCap":51063680},{"date":"2022-07-08","current":-2.141609,"twenty":-9.079887,"median":-2.128772,"eighty":-1.362564,"marketCap":52240263},{"date":"2022-07-15","current":-2.083727,"twenty":-9.079887,"median":-2.129233,"eighty":-1.365604,"marketCap":50828364},{"date":"2022-07-22","current":-2.04514,"twenty":-9.079887,"median":-2.129233,"eighty":-1.382433,"marketCap":49887098},{"date":"2022-07-29","current":-2.04514,"twenty":-9.079887,"median":-2.129233,"eighty":-1.400792,"marketCap":49887098},{"date":"2022-08-05","current":-2.122315,"twenty":-9.079887,"median":-2.129233,"eighty":-1.416087,"marketCap":51769630},{"date":"2022-08-12","current":-2.363487,"twenty":-9.079887,"median":-2.141609,"eighty":-1.428705,"marketCap":57652542},{"date":"2022-08-19","current":-3.229692,"twenty":-9.079887,"median":-2.151454,"eighty":-1.454072,"marketCap":59704090},{"date":"2022-08-26","current":-3.175864,"twenty":-9.079887,"median":-2.160903,"eighty":-1.46638,"marketCap":58709022},{"date":"2022-09-02","current":-2.933637,"twenty":-9.079887,"median":-2.168513,"eighty":-1.513357,"marketCap":54231215},{"date":"2022-09-09","current":-2.866352,"twenty":-9.079887,"median":-2.173457,"eighty":-1.552879,"marketCap":52987380},{"date":"2022-09-16","current":-3.068208,"twenty":-9.079887,"median":-2.185224,"eighty":-1.597561,"marketCap":56718886},{"date":"2022-09-23","current":-2.772152,"twenty":-9.079887,"median":-2.19473,"eighty":-1.642895,"marketCap":51246011},{"date":"2022-09-30","current":-2.802835,"twenty":-9.079887,"median":-2.19949,"eighty":-1.691667,"marketCap":51813200},{"date":"2022-10-07","current":-2.799067,"twenty":-9.079887,"median":-2.205652,"eighty":-1.708303,"marketCap":51743545},{"date":"2022-10-14","current":-2.745238,"twenty":-9.079887,"median":-2.213275,"eighty":-1.720523,"marketCap":50748477},{"date":"2022-10-21","current":-2.772152,"twenty":-9.079887,"median":-2.225261,"eighty":-1.725838,"marketCap":51246011},{"date":"2022-10-28","current":-2.772152,"twenty":-9.079887,"median":-2.240109,"eighty":-1.732273,"marketCap":51246011},{"date":"2022-11-04","current":-2.718324,"twenty":-9.079887,"median":-2.242805,"eighty":-1.755663,"marketCap":50250943},{"date":"2022-11-11","current":-2.825981,"twenty":-9.079887,"median":-2.250369,"eighty":-1.765675,"marketCap":52241079},{"date":"2022-11-18","current":-3.036417,"twenty":-9.079887,"median":-2.262195,"eighty":-1.778799,"marketCap":54212189},{"date":"2022-11-25","current":-3.391139,"twenty":-9.079887,"median":-2.26358,"eighty":-1.789218,"marketCap":60545389},{"date":"2022-12-02","current":-3.206683,"twenty":-9.079887,"median":-2.278354,"eighty":-1.795365,"marketCap":57252125},{"date":"2022-12-09","current":-3.320194,"twenty":-9.079887,"median":-2.292748,"eighty":-1.799662,"marketCap":59278749},{"date":"2022-12-16","current":-3.291817,"twenty":-9.079887,"median":-2.300018,"eighty":-1.807377,"marketCap":58772093},{"date":"2022-12-23","current":-3.348572,"twenty":-9.079887,"median":-2.308362,"eighty":-1.815181,"marketCap":59785405},{"date":"2022-12-30","current":-3.887749,"twenty":-9.079887,"median":-2.330304,"eighty":-1.816065,"marketCap":69411869},{"date":"2023-01-06","current":-4.341793,"twenty":-9.079887,"median":-2.331425,"eighty":-1.819992,"marketCap":77518364},{"date":"2023-01-13","current":-4.597192,"twenty":-9.079887,"median":-2.347715,"eighty":-1.827125,"marketCap":82078268},{"date":"2023-01-20","current":-4.739081,"twenty":-9.079887,"median":-2.35453,"eighty":-1.836965,"marketCap":84611548},{"date":"2023-01-27","current":-4.455303,"twenty":-9.079887,"median":-2.366765,"eighty":-1.846672,"marketCap":79544988},{"date":"2023-02-03","current":-4.597192,"twenty":-9.079887,"median":-2.372929,"eighty":-1.855292,"marketCap":82078268},{"date":"2023-02-10","current":-4.483681,"twenty":-9.079887,"median":-2.377975,"eighty":-1.863262,"marketCap":80051644},{"date":"2023-02-17","current":-4.426926,"twenty":-9.079887,"median":-2.386937,"eighty":-1.865474,"marketCap":79038332},{"date":"2023-02-24","current":-5.164747,"twenty":-9.079887,"median":-2.395361,"eighty":-1.8693,"marketCap":92211388},{"date":"2023-03-03","current":-7.880419,"twenty":-9.079887,"median":-2.409349,"eighty":-1.87939,"marketCap":117631009},{"date":"2023-03-10","current":-7.111597,"twenty":-9.079887,"median":-2.414353,"eighty":-1.887277,"marketCap":106154813},{"date":"2023-03-17","current":-7.803536,"twenty":-9.079887,"median":-2.420155,"eighty":-1.897474,"marketCap":116483389},{"date":"2023-03-24","current":-7.649772,"twenty":-9.079887,"median":-2.433443,"eighty":-1.901141,"marketCap":114188150},{"date":"2023-03-31","current":-8.072624,"twenty":-9.073245,"median":-2.439918,"eighty":-1.90865,"marketCap":120500058},{"date":"2023-04-06","current":-8.226388,"twenty":-9.073245,"median":-2.446146,"eighty":-1.912148,"marketCap":122795297},{"date":"2023-04-14","current":-9.571826,"twenty":-9.400542,"median":-2.46771,"eighty":-1.922938,"marketCap":142878640},{"date":"2023-04-21","current":-8.956768,"twenty":-9.457132,"median":-2.480199,"eighty":-1.931683,"marketCap":133697683},{"date":"2023-04-28","current":-10.263765,"twenty":-9.567591,"median":-2.502031,"eighty":-1.934828,"marketCap":153207216},{"date":"2023-05-05","current":-14.724601,"twenty":-9.651117,"median":-2.520118,"eighty":-1.939455,"marketCap":219794121},{"date":"2023-05-12","current":-10.576213,"twenty":-10.196717,"median":-2.536056,"eighty":-1.94368,"marketCap":166808038},{"date":"2023-05-19","current":-9.162809,"twenty":-10.196717,"median":-2.545576,"eighty":-1.945022,"marketCap":144515819},{"date":"2023-05-26","current":-8.948724,"twenty":-10.196717,"median":-2.560684,"eighty":-1.945022,"marketCap":141139282},{"date":"2023-06-02","current":-9.162809,"twenty":-10.196717,"median":-2.582062,"eighty":-1.945022,"marketCap":144515819},{"date":"2023-06-09","current":-9.976329,"twenty":-10.332959,"median":-2.61351,"eighty":-1.945022,"marketCap":157346663},{"date":"2023-06-16","current":-9.633794,"twenty":-10.332959,"median":-2.630673,"eighty":-1.945022,"marketCap":151944203},{"date":"2023-06-23","current":-9.505344,"twenty":-10.356023,"median":-2.656774,"eighty":-1.945022,"marketCap":149918280},{"date":"2023-06-30","current":-9.291259,"twenty":-10.379088,"median":-2.691448,"eighty":-1.945022,"marketCap":146541742},{"date":"2023-07-07","current":-7.664219,"twenty":-10.379088,"median":-2.708789,"eighty":-1.945022,"marketCap":120880055},{"date":"2023-07-14","current":-7.664219,"twenty":-10.379088,"median":-2.729688,"eighty":-1.945022,"marketCap":120880055},{"date":"2023-07-21","current":-7.364501,"twenty":-10.379088,"median":-2.745103,"eighty":-1.945022,"marketCap":116152902},{"date":"2023-07-28","current":-7.150416,"twenty":-10.379088,"median":-2.745238,"eighty":-1.945022,"marketCap":112776364},{"date":"2023-08-04","current":-7.364501,"twenty":-10.38417,"median":-2.755336,"eighty":-1.944575,"marketCap":116152902},{"date":"2023-08-11","current":15.199151,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":135287640},{"date":"2023-08-18","current":15.359988,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":136719255},{"date":"2023-08-25","current":16.244595,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":144593139},{"date":"2023-09-01","current":15.199151,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":135287640},{"date":"2023-09-08","current":14.797057,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":131708602},{"date":"2023-09-15","current":13.91245,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":123834718},{"date":"2023-09-22","current":13.349518,"twenty":-10.38417,"median":-2.755336,"eighty":-1.937003,"marketCap":118824064},{"date":"2023-09-29","current":12.947425,"twenty":-10.38417,"median":-2.755336,"eighty":-1.931683,"marketCap":115245026},{"date":"2023-10-06","current":12.867006,"twenty":-10.38417,"median":-2.74793,"eighty":-1.924528,"marketCap":114529219},{"date":"2023-10-13","current":11.982399,"twenty":-10.38417,"median":-2.74793,"eighty":-1.91452,"marketCap":106655335},{"date":"2023-10-20","current":11.741143,"twenty":-10.38417,"median":-2.74793,"eighty":-1.909391,"marketCap":104507912},{"date":"2023-10-27","current":11.982399,"twenty":-10.399416,"median":-2.764616,"eighty":-1.90816,"marketCap":106655335},{"date":"2023-11-03","current":13.590775,"twenty":-10.399416,"median":-2.764616,"eighty":-1.90816,"marketCap":120971487},{"date":"2023-11-10","current":9.551945,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899704,"marketCap":101403452},{"date":"2023-11-17","current":9.551945,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":101403452},{"date":"2023-11-24","current":9.826821,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":104321537},{"date":"2023-12-01","current":10.376574,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":110157707},{"date":"2023-12-08","current":11.682235,"twenty":-10.394334,"median":-2.758695,"eighty":-1.898511,"marketCap":124018610},{"date":"2023-12-15","current":12.09455,"twenty":-10.394334,"median":-2.758695,"eighty":-1.898511,"marketCap":128395738},{"date":"2023-12-22","current":11.957111,"twenty":-10.394334,"median":-2.758695,"eighty":-1.898511,"marketCap":126936695},{"date":"2023-12-29","current":12.369426,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":131313823},{"date":"2024-01-05","current":11.957111,"twenty":-10.404498,"median":-2.770538,"eighty":-1.89955,"marketCap":126936695},{"date":"2024-01-12","current":11.269921,"twenty":-10.404498,"median":-2.770538,"eighty":-1.89955,"marketCap":119641483},{"date":"2024-01-19","current":10.101698,"twenty":-10.438841,"median":-2.771211,"eighty":-1.899583,"marketCap":107239622},{"date":"2024-01-26","current":10.376574,"twenty":-10.404498,"median":-2.770538,"eighty":-1.898048,"marketCap":110157707},{"date":"2024-02-02","current":10.101698,"twenty":-10.404498,"median":-2.770538,"eighty":-1.887499,"marketCap":107239622},{"date":"2024-02-09","current":10.307855,"twenty":-10.404498,"median":-2.770538,"eighty":-1.878194,"marketCap":109428186},{"date":"2024-02-16","current":10.445293,"twenty":-10.404498,"median":-2.770538,"eighty":-1.865074,"marketCap":110887228},{"date":"2024-02-23","current":9.826821,"twenty":-10.404498,"median":-2.770538,"eighty":-1.859242,"marketCap":104321537},{"date":"2024-03-01","current":11.201202,"twenty":-10.399416,"median":-2.764616,"eighty":-1.84065,"marketCap":118911962},{"date":"2024-03-08","current":10.032979,"twenty":-10.399416,"median":-2.764616,"eighty":-1.815126,"marketCap":106510101},{"date":"2024-03-15","current":12.024111,"twenty":-10.399416,"median":-2.764616,"eighty":-1.798801,"marketCap":99944409},{"date":"2024-03-22","current":11.601155,"twenty":-10.399416,"median":-2.753312,"eighty":-1.765715,"marketCap":96428803},{"date":"2024-03-28","current":10.985943,"twenty":-10.399416,"median":-2.753312,"eighty":-1.731141,"marketCap":91315155},{"date":"2024-04-05","current":10.634392,"twenty":-10.404498,"median":-2.758695,"eighty":-1.704982,"marketCap":88393070},{"date":"2024-04-12","current":10.72228,"twenty":-10.404498,"median":-2.758695,"eighty":-1.630901,"marketCap":89123591},{"date":"2024-04-19","current":9.931292,"twenty":-10.404498,"median":-2.758695,"eighty":-1.553621,"marketCap":82548900},{"date":"2024-04-26","current":10.37073,"twenty":-10.399416,"median":-2.753312,"eighty":-1.502768,"marketCap":86201506},{"date":"2024-05-03","current":10.231792,"twenty":-10.399416,"median":-2.753312,"eighty":-1.45681,"marketCap":85046657},{"date":"2024-05-10","current":11.025638,"twenty":-10.399416,"median":-2.753312,"eighty":-1.426977,"marketCap":91645105},{"date":"2024-05-17","current":12.526258,"twenty":-10.399416,"median":-2.753312,"eighty":-1.393687,"marketCap":85779818},{"date":"2024-05-24","current":12.633321,"twenty":-10.399416,"median":-2.753312,"eighty":-1.35988,"marketCap":86512979},{"date":"2024-05-31","current":12.205072,"twenty":-10.399416,"median":-2.753312,"eighty":-1.337474,"marketCap":83580335},{"date":"2024-06-07","current":12.09801,"twenty":-10.399416,"median":-2.746584,"eighty":-1.32008,"marketCap":82847174},{"date":"2024-06-14","current":12.419196,"twenty":-10.404498,"median":-2.745238,"eighty":-1.307985,"marketCap":85046657},{"date":"2024-06-21","current":12.526258,"twenty":-10.438841,"median":-2.746584,"eighty":-1.281516,"marketCap":85779818},{"date":"2024-06-28","current":13.811003,"twenty":-10.54187,"median":-2.758695,"eighty":-1.257877,"marketCap":94577748},{"date":"2024-07-05","current":11.134452,"twenty":-10.54187,"median":-2.758695,"eighty":-1.2431,"marketCap":76248727},{"date":"2024-07-12","current":12.205072,"twenty":-10.54187,"median":-2.758695,"eighty":-1.222499,"marketCap":83580335},{"date":"2024-07-15","current":12.205072,"twenty":-10.54187,"median":-2.758695,"eighty":-1.212089,"marketCap":83580335},{"date":"2024-08-02","current":11.348576,"twenty":-11.649165,"median":-2.772152,"eighty":-1.193601,"marketCap":77715049},{"date":"2024-08-09","current":11.134452,"twenty":-11.649165,"median":-2.772152,"eighty":-1.178742,"marketCap":76248727},{"date":"2024-08-16","current":-4.754699,"twenty":-11.649165,"median":-2.772152,"eighty":-1.164919,"marketCap":69865540},{"date":"2024-08-23","current":-4.697142,"twenty":-11.649165,"median":-2.793651,"eighty":-1.164919,"marketCap":69019799},{"date":"2024-08-30","current":-4.555001,"twenty":-11.649165,"median":-2.799067,"eighty":-1.164919,"marketCap":66931187},{"date":"2024-09-06","current":-5.105045,"twenty":-11.649165,"median":-2.825981,"eighty":-1.172176,"marketCap":75013527},{"date":"2024-09-13","current":-5.305243,"twenty":-11.649165,"median":-2.832709,"eighty":-1.172176,"marketCap":77955234},{"date":"2024-09-20","current":-5.755688,"twenty":-11.649165,"median":-2.864199,"eighty":-1.172176,"marketCap":84574075},{"date":"2024-09-27","current":-5.355292,"twenty":-11.649165,"median":-2.877542,"eighty":-1.183349,"marketCap":78690661},{"date":"2024-10-04","current":-5.054995,"twenty":-11.649165,"median":-2.919172,"eighty":-1.235399,"marketCap":74278100},{"date":"2024-10-11","current":-5.004946,"twenty":-11.649165,"median":-2.926909,"eighty":-1.318237,"marketCap":73542674},{"date":"2024-10-18","current":-5.455391,"twenty":-11.649165,"median":-2.961811,"eighty":-1.343261,"marketCap":80161514},{"date":"2024-10-25","current":-5.155094,"twenty":-11.649165,"median":-3.006085,"eighty":-1.359997,"marketCap":75748954},{"date":"2024-10-31","current":-5.855787,"twenty":-11.649165,"median":-3.008039,"eighty":-1.398056,"marketCap":86044928},{"date":"2024-11-08","current":-5.805737,"twenty":-11.689082,"median":-3.036417,"eighty":-1.525183,"marketCap":85309501},{"date":"2024-11-15","current":-7.056974,"twenty":-11.689082,"median":-3.072813,"eighty":-1.58483,"marketCap":103695170},{"date":"2024-11-22","current":-12.724521,"twenty":-11.98416,"median":-3.14895,"eighty":-1.643965,"marketCap":122231747},{"date":"2024-11-29","current":-13.184443,"twenty":-12.17163,"median":-3.149928,"eighty":-1.708859,"marketCap":126649762},{"date":"2024-12-06","current":-12.49456,"twenty":-12.366043,"median":-3.229692,"eighty":-1.708859,"marketCap":120022740},{"date":"2024-12-13","current":-13.797673,"twenty":-12.463249,"median":-3.291817,"eighty":-1.71628,"marketCap":132540449},{"date":"2024-12-20","current":-13.337751,"twenty":-12.497966,"median":-3.310435,"eighty":-1.73821,"marketCap":128122434},{"date":"2024-12-27","current":-13.644366,"twenty":-12.532682,"median":-3.320194,"eighty":-1.780748,"marketCap":131067777},{"date":"2025-01-03","current":-15.100787,"twenty":-12.605949,"median":-3.348572,"eighty":-1.788536,"marketCap":145058158},{"date":"2025-01-10","current":-17.400399,"twenty":-12.708302,"median":-3.419516,"eighty":-1.785226,"marketCap":167148233},{"date":"2025-01-17","current":-16.633862,"twenty":-12.808567,"median":-3.52276,"eighty":-1.785226,"marketCap":159784875},{"date":"2025-01-24","current":-19.393396,"twenty":-12.953442,"median":-3.648888,"eighty":-1.785226,"marketCap":186292964},{"date":"2025-01-31","current":-18.24359,"twenty":-13.053431,"median":-3.807696,"eighty":-1.785226,"marketCap":175247927},{"date":"2025-02-07","current":-20.619856,"twenty":-13.179071,"median":-3.887749,"eighty":-1.785226,"marketCap":198074338},{"date":"2025-02-14","current":-20.389895,"twenty":-13.360254,"median":-4.058015,"eighty":-1.785226,"marketCap":195865330},{"date":"2025-02-21","current":-18.626859,"twenty":-13.491058,"median":-4.162726,"eighty":-1.785226,"marketCap":178929606},{"date":"2025-02-28","current":-17.860321,"twenty":-13.571831,"median":-4.258509,"eighty":-1.785226,"marketCap":171566248},{"date":"2025-03-07","current":-18.166936,"twenty":-13.797673,"median":-4.37017,"eighty":-1.781917,"marketCap":174511591},{"date":"2025-03-14","current":-16.633862,"twenty":-14.027634,"median":-4.426926,"eighty":-1.806013,"marketCap":159784875},{"date":"2025-03-21","current":62.809311,"twenty":-14.199078,"median":-4.426926,"eighty":-1.781917,"marketCap":184156900},{"date":"2025-03-28","current":68.664416,"twenty":-14.199078,"median":-4.426926,"eighty":-1.731486,"marketCap":201324069},{"date":"2025-04-04","current":69.196699,"twenty":-14.199078,"median":-4.426926,"eighty":9.414507,"marketCap":202884721},{"date":"2025-04-11","current":61.478605,"twenty":-14.164789,"median":-4.426926,"eighty":9.60692,"marketCap":180255271},{"date":"2025-04-17","current":69.196699,"twenty":-14.164789,"median":-4.37017,"eighty":9.758102,"marketCap":202884721},{"date":"2025-04-25","current":78.245498,"twenty":-14.199078,"median":-4.058015,"eighty":9.826821,"marketCap":229415799},{"date":"2025-05-02","current":79.842345,"twenty":-14.199078,"median":-3.731273,"eighty":9.895541,"marketCap":234097755},{"date":"2025-05-09","current":76.914792,"twenty":-14.199078,"median":-3.62153,"eighty":10.01918,"marketCap":225514170},{"date":"2025-05-16","current":34.018394,"twenty":-14.199078,"median":-3.44594,"eighty":10.055382,"marketCap":132943882},{"date":"2025-05-23","current":33.610987,"twenty":-14.199078,"median":-3.37695,"eighty":10.101698,"marketCap":131351739},{"date":"2025-05-30","current":32.38877,"twenty":-14.199078,"median":-3.34545,"eighty":10.107067,"marketCap":126575312},{"date":"2025-06-06","current":30.962849,"twenty":-14.199078,"median":-3.320194,"eighty":10.170417,"marketCap":121002814},{"date":"2025-06-13","current":31.370255,"twenty":-14.199078,"median":-3.291817,"eighty":10.239136,"marketCap":122594957},{"date":"2025-06-20","current":28.518414,"twenty":-14.027634,"median":-3.241732,"eighty":10.37073,"marketCap":111449961},{"date":"2025-06-27","current":29.536928,"twenty":-13.848978,"median":-3.190184,"eighty":10.376574,"marketCap":115430316},{"date":"2025-07-03","current":31.370255,"twenty":-13.848978,"median":-3.149439,"eighty":10.459037,"marketCap":122594957},{"date":"2025-07-11","current":30.148037,"twenty":-13.848978,"median":-3.108336,"eighty":10.583107,"marketCap":117818530},{"date":"2025-07-18","current":30.555443,"twenty":-13.848978,"median":-3.054751,"eighty":10.65145,"marketCap":119410672},{"date":"2025-07-25","current":31.573958,"twenty":-13.848978,"median":-3.021648,"eighty":10.720591,"marketCap":123391028},{"date":"2025-08-01","current":29.740631,"twenty":-13.848978,"median":-3.006967,"eighty":10.793764,"marketCap":116226387},{"date":"2025-08-08","current":30.759146,"twenty":-13.848978,"median":-2.971366,"eighty":10.903709,"marketCap":120206743},{"date":"2025-08-15","current":19.313596,"twenty":-13.644366,"median":-2.937379,"eighty":11.065777,"marketCap":121192814},{"date":"2025-08-22","current":20.075975,"twenty":-13.429736,"median":-2.919172,"eighty":11.134452,"marketCap":125976741},{"date":"2025-08-29","current":19.694785,"twenty":-13.123121,"median":-2.8825,"eighty":11.169615,"marketCap":123584778},{"date":"2025-09-05","current":20.203038,"twenty":-12.90849,"median":-2.875275,"eighty":11.241514,"marketCap":126774062},{"date":"2025-09-12","current":22.108985,"twenty":-12.628566,"median":-2.846166,"eighty":11.42538,"marketCap":138733880},{"date":"2025-09-19","current":23.633742,"twenty":-12.250828,"median":-2.825981,"eighty":11.601155,"marketCap":148301733},{"date":"2025-09-26","current":25.920879,"twenty":-10.604625,"median":-2.799067,"eighty":11.743105,"marketCap":162653514},{"date":"2025-10-03","current":29.732773,"twenty":-10.114998,"median":-2.793273,"eighty":11.832516,"marketCap":186573149},{"date":"2025-10-10","current":32.528162,"twenty":-9.805062,"median":-2.772152,"eighty":11.957111,"marketCap":204114214},{"date":"2025-10-17","current":30.495152,"twenty":-9.762245,"median":-2.772018,"eighty":11.990948,"marketCap":191357076},{"date":"2025-10-24","current":29.351583,"twenty":-9.666843,"median":-2.745238,"eighty":12.062818,"marketCap":184181185},{"date":"2025-10-31","current":28.716268,"twenty":-9.575656,"median":-2.745238,"eighty":12.09801,"marketCap":180194579},{"date":"2025-11-07","current":28.208015,"twenty":-9.495624,"median":-2.743583,"eighty":12.205072,"marketCap":177005295},{"date":"2025-11-14","current":24.73512,"twenty":-9.387308,"median":-2.699686,"eighty":12.300707,"marketCap":155212879},{"date":"2025-11-21","current":25.942316,"twenty":-9.269689,"median":-2.615734,"eighty":12.37938,"marketCap":139932854},{"date":"2025-11-28","current":26.538692,"twenty":-9.163458,"median":-2.567994,"eighty":12.464912,"marketCap":143149702},{"date":"2025-12-05","current":26.09141,"twenty":-9.067701,"median":-2.545381,"eighty":12.526258,"marketCap":140737066},{"date":"2025-12-12","current":27.28416,"twenty":-8.948724,"median":-2.50209,"eighty":12.602031,"marketCap":147170761},{"date":"2025-12-19","current":26.836879,"twenty":-8.571936,"median":-2.480199,"eighty":12.656675,"marketCap":144758125},{"date":"2025-12-26","current":26.389598,"twenty":-8.326335,"median":-2.442358,"eighty":12.851357,"marketCap":142345490},{"date":"2026-01-02","current":26.836879,"twenty":-8.103377,"median":-2.417254,"eighty":13.056001,"marketCap":144758125},{"date":"2026-01-09","current":29.818755,"twenty":-7.958628,"median":-2.392428,"eighty":13.349518,"marketCap":160842362},{"date":"2026-01-16","current":30.713317,"twenty":-7.818489,"median":-2.365591,"eighty":13.606859,"marketCap":165667632},{"date":"2026-01-23","current":31.160598,"twenty":-7.77061,"median":-2.332944,"eighty":13.811003,"marketCap":168080268},{"date":"2026-01-30","current":30.862411,"twenty":-7.691977,"median":-2.280199,"eighty":14.105455,"marketCap":166471844},{"date":"2026-02-05","current":43.237194,"twenty":-7.664219,"median":-2.25376,"eighty":14.732722,"marketCap":233221424}],"updateTime":1770445942106},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PLX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608893279","title":"Protalix BioTherapeutics Shares Up After CHMP Issued Positive Opinion on New Dosing Regimen for Fabry Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2608893279","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608893279?lang=en_us&edition=fundamental","pubTime":"2026-02-03 00:00","pubTimestamp":1770048000,"startTime":"0","endTime":"0","summary":"Shares of Protalix BioTherapeutics jumped after the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion on a new dosing regimen of its Fabry disease treatment.The stock rose 7.9% to $2.53 in Monday morning trading. The shares have increased 3% in the past year.The biopharmaceutical company focused on rare diseases said Monday that the committee gave a positive opinion of a new dosing regimen of 2 mg per kilogram every four weeks for Protalix's Elfabrio drug.The opinion will be reviewed by the European Commission with a decision anticipated by March. If approved, Elfabrio will be available in two doses, including the already approved regimen of 1 mg per kilogram every two weeks, to patients in the European Union.Protalix, and its collaborator Chiesi Global's rare diseases unit, said the new regimen could reduce the burden to eligible patients and their families by alleviating the current requirement to visit infusion centers every two wee","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLX","BK4087","CHMP"],"gpt_icon":0},{"id":"2607047855","title":"Protalix Fabry Disease Treatment Recommended for Approval by EMA Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2607047855","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607047855?lang=en_us&edition=fundamental","pubTime":"2026-01-30 23:32","pubTimestamp":1769787142,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics and Chiesi Global Rare Diseases said Friday that Elfabrio, an enzyme replacement therapy to treat Fabry disease, has received a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency.Protalix will be eligible to receive a regulatory milestone payment of $25 million if the treatment is approved by the European Commission, the companies said.Protalix shares were more than 7% higher in recent trading.Price: 2.26, Change: +0.18, Percent Change: +8.41","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","EMA","PLX","BK4081"],"gpt_icon":0},{"id":"2607041098","title":"CHMP Recommends Approval of New Elfabrio Dosing Regimen for Protalix BioTherapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2607041098","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607041098?lang=en_us&edition=fundamental","pubTime":"2026-01-30 22:48","pubTimestamp":1769784481,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc. and Chiesi Global Rare Diseases announced that the Committee for Medicinal Products for Human Use  of the European Medicines Agency  has issued a positive opinion recommending the approval of a new dosing regimen for Elfabrio  in the European Union. The recommended regimen is 2 mg/kg every four weeks for adult Fabry disease patients who are stable on enzyme replacement therapy. The CHMP's opinion follows a re-examination of the application and will be reviewed by the European Commission, with a decision expected by March 2026. If approved, this regimen would offer an alternative to the current treatment schedule, which requires infusions every two weeks. This dosing regimen is not currently approved in the United States, where the approved regimen remains 1 mg/kg every two weeks.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-gen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDL2t9FRv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4585","LU0314104364.USD","IE00BKPKM429.USD","SG9999014005.SGD","BK4588","SG9999014013.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","NDAQ","BK4112","LU2210150020.SGD","LU2210149790.SGD","PLX","IE00BGHQF748.EUR","BK4139","SG9999014039.USD","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2605426714","title":"PLUXEE N.V. (PLX) Receives a Buy from Kepler Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2605426714","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605426714?lang=en_us&edition=fundamental","pubTime":"2026-01-23 09:51","pubTimestamp":1769133073,"startTime":"0","endTime":"0","summary":"Kepler Capital analyst Julien Richer maintained a Buy rating on PLUXEE N.V. on January 21 and set a price target of €18.00. The company’s shares cl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pluxee-n-v-plx-receives-a-buy-from-kepler-capital-blurbs-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pluxee-n-v-plx-receives-a-buy-from-kepler-capital-blurbs-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2601885135","title":"Protalix BioTherapeutics Projects Profitable Growth Anchored by Elfabrio Sales in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601885135","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601885135?lang=en_us&edition=fundamental","pubTime":"2026-01-05 19:50","pubTimestamp":1767613816,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc. announced that it enters 2026 with a profitable commercial business through its partners and a focused pipeline targeting high unmet medical needs. The company expects future sales to continue being anchored by Elfabrio, marketed by partner Chiesi in the United States and key international markets. Protalix projects that Elfabrio is positioned to capture 15% to 20% of the global Fabry market, which is estimated to reach approximately $3.4 billion by 2030. The company remains committed to advancing its pipeline, including potential therapies for uncontrolled gout and rare renal diseases, while expanding its commercial footprint and pursuing strategic partnerships to accelerate growth and scale.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as finan","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDL6NBN02:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2593904497","title":"Protalix BioTherapeutics CEO Dror Bashan Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2593904497","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593904497?lang=en_us&edition=fundamental","pubTime":"2025-12-23 20:26","pubTimestamp":1766492792,"startTime":"0","endTime":"0","summary":"Dror Bashan, President and CEO of Protalix BioTherapeutics Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protalix BioTherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 23, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL3TypGn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Protalix BioTherapeutics CEO Dror Bashan Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2592994499","title":"Protalix BioTherapeutics and Secarna Pharmaceuticals partner to develop rare kidney disease therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2592994499","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592994499?lang=en_us&edition=fundamental","pubTime":"2025-12-17 19:50","pubTimestamp":1765972217,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc. has announced a collaboration and option agreement with Secarna Pharmaceuticals GmbH & Co. KG to jointly develop novel antisense oligonucleotide  therapies for rare renal diseases. The partnership will combine Protalix's expertise in rare disease biologics with Secarna's AI-powered OligoCreator platform to discover and advance new pharmaceutical candidates. Under the agreement, Protalix is granted an exclusive option to license any active compounds resulting from the research for clinical development and commercialization, marking Protalix's first expansion into rare kidney disease therapies using RNA technologies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protalix BioTherapeutics Inc. published the o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL3sZgZP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2585117664","title":"Protalix BioTherapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2585117664","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585117664?lang=en_us&edition=fundamental","pubTime":"2025-11-21 19:31","pubTimestamp":1763724660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PLX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 21, 2025 06:31 ET (11:31 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX"],"gpt_icon":0},{"id":"2585422112","title":"Protalix price target lowered to $12 from $15 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2585422112","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585422112?lang=en_us&edition=fundamental","pubTime":"2025-11-21 19:10","pubTimestamp":1763723430,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Raghuram Selvaraju lowered the firm’s price target on Protalix (PLX) to $12 from $15 and keeps a Buy rating on the shares f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protalix-price-target-lowered-to-12-from-15-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protalix-price-target-lowered-to-12-from-15-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2584922820","title":"Protalix BioTherapeutics Q3 EPS USD 0.03","url":"https://stock-news.laohu8.com/highlight/detail?id=2584922820","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584922820?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:37","pubTimestamp":1763573856,"startTime":"0","endTime":"0","summary":"Nov 13 (Reuters) - Protalix BioTherapeutics Q3 pretax profit USD 2.239 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 13-NOV-202511:00:00.18 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD6SWMs1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2584925534","title":"Chiesi Global Rare Diseases Seeks Ema Chmp Re-Exam Of Negative View On Elfabrio 2 Mg/Kg Q4w Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2584925534","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584925534?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:27","pubTimestamp":1763569669,"startTime":"0","endTime":"0","summary":"Nov 3 (Reuters) - CHIESI GLOBAL RARE DISEASES-:*CHIESI GLOBAL RARE DISEASES - REQUESTS RE-EXAMINATION OF NEGATIVE OPINION ISSUED BY EMA'S CHMP ON PROPOSED DOSING REGIMEN OF 2 MG/KG EVERY 4 WEEKS FOR E","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD1lLSpJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2584776999","title":"Bernstein Remains a Hold on PLUXEE N.V. (PLX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584776999","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584776999?lang=en_us&edition=fundamental","pubTime":"2025-11-19 11:16","pubTimestamp":1763522162,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Sabrina Blanc from Bernstein maintained a Hold rating on PLUXEE N.V.. The company’s shares closed last Monday at €1...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-hold-on-pluxee-n-v-plx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-hold-on-pluxee-n-v-plx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2584930939","title":"Kepler Capital  Remains a Buy on PLUXEE N.V. (PLX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584930939","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584930939?lang=en_us&edition=fundamental","pubTime":"2025-11-19 09:46","pubTimestamp":1763516767,"startTime":"0","endTime":"0","summary":"In a report released on November 17, Julien Richer from Kepler Capital maintained a Buy rating on PLUXEE N.V., with a price target of €28.00. The c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/kepler-capital-remains-a-buy-on-pluxee-n-v-plx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/kepler-capital-remains-a-buy-on-pluxee-n-v-plx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2584876479","title":"Protalix BioTherapeutics showcases pipeline advances and growth strategy for rare disease treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2584876479","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584876479?lang=en_us&edition=fundamental","pubTime":"2025-11-18 16:56","pubTimestamp":1763456200,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc. has provided an update on its clinical and commercial pipeline. The company reported $53 million in revenue for the full year 2024 and $25.4 million in revenue from selling goods during the first half of 2025. As of June 30, 2025, Protalix holds $33.4 million in cash, with no debt or outstanding warrants, and anticipates becoming cash flow positive in the first half of 2027. The company's commercial portfolio includes approved enzyme replacement therapies for Fabry disease and Gaucher disease, with market presence in the US, EU, and additional regions. In its development pipeline, Protalix highlights PRX-115, a recombinant PEGylated uricase candidate for uncontrolled gout, with Phase 2 studies expected to begin in the fourth quarter of 2025. The company also reports ongoing research in rare renal diseases and other NETs-related diseases. Key upcoming milestones include expanding market share for existing products, pursuing additional geographic approvals, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL8VvndK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2584840579","title":"Barclays Keeps Their Hold Rating on PLUXEE N.V. (PLX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584840579","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584840579?lang=en_us&edition=fundamental","pubTime":"2025-11-18 16:16","pubTimestamp":1763453779,"startTime":"0","endTime":"0","summary":"Barclays analyst Pravin Gondhale maintained a Hold rating on PLUXEE N.V. today and set a price target of €20.00. According to TipRanks, Gondhale is...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-keeps-their-hold-rating-on-pluxee-n-v-plx-blurbs-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-keeps-their-hold-rating-on-pluxee-n-v-plx-blurbs-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLX"],"gpt_icon":0},{"id":"2583254938","title":"Protalix BioTherapeutics’ Earnings Call Highlights Growth and Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2583254938","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583254938?lang=en_us&edition=fundamental","pubTime":"2025-11-14 08:37","pubTimestamp":1763080660,"startTime":"0","endTime":"0","summary":"Protalix Biotherapeutics (($PLX)) has held its Q3 earnings call. Read on for the main highlights of the call. Protalix BioTherapeutics’ recent earn...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/protalix-biotherapeutics-earnings-call-highlights-growth-and-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/protalix-biotherapeutics-earnings-call-highlights-growth-and-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLX"],"gpt_icon":0},{"id":"2583636562","title":"Protalix BioTherapeutics Q3 EPS USD 0.03","url":"https://stock-news.laohu8.com/highlight/detail?id=2583636562","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583636562?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:04","pubTimestamp":1763035494,"startTime":"0","endTime":"0","summary":"Nov 13 (Reuters) - Protalix BioTherapeutics Q3 pretax profit USD 2.239 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 13-NOV-202511:00:00.18 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nRSD6SWMs1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2583564535","title":"Protalix BioTherapeutics Q3 EPS $0.03 Misses $0.06 Estimate, Sales $17.673M Miss $17.866M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583564535","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583564535?lang=en_us&edition=fundamental","pubTime":"2025-11-13 19:51","pubTimestamp":1763034676,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics (AMEX:PLX) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.06 by 45.45 percent. This is unchanged from the same period last year.  The company","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48829545/protalix-biotherapeutics-q3-eps-0-03-misses-0-06-estimate-sales-17-673m-miss-17-866m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX"],"gpt_icon":0},{"id":"2583566564","title":"Press Release: Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2583566564","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583566564?lang=en_us&edition=fundamental","pubTime":"2025-11-13 19:50","pubTimestamp":1763034600,"startTime":"0","endTime":"0","summary":"Company to host conference call and webcast today at 8:00 a.m. EST. CARMIEL, Israel, Nov. 13, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cell-based protein expression system, today reported financial results for the quarter ended September 30, 2025, and provided a financial and business update.\"We are pleased to report total revenues of $43.6 million for the first nine months of 2025, an increase of 24%, compared to the same period in 2024. Our total revenues for the third quarter were $17.9 million which reflects a decrease of 1%, compared to revenues for the same period of 2024,\" said Dror Bashan, Protalix's President and Chief Executive Officer. \"We recognize revenues from sales of our products to Chiesi, Pfizer, and Fiocruz in Brazil, and their purchases vary from quarter to quarter as they control their ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999013999.USD","LU0234572021.USD","SG9999003800.SGD","LU0170899867.USD","BK4585","LU1894683264.USD","SG9999001176.SGD","CHMP","LU0225771236.USD","LU1066051498.USD","LU1066053197.SGD","BK4581","LU1057294990.SGD","R","IE00B19Z3581.USD","LU0289739699.SGD","BK4592","IE000M9KFDE8.USD","LU0058720904.USD","BK4568","BK4533","PLX","SGXZ57979304.SGD","BK4007","IE00BBT3K403.USD","LU0321505439.SGD","LU1883839398.USD","SG9999002232.USD","LU0306806265.USD","BK4139","BK4081","LU0225284248.USD","LU0306807586.USD","LU0985481810.HKD","BK4599","LU0456855351.SGD","SG9999001176.USD","IE0002270589.USD","EMA","LU0122379950.USD","BK4022","SG9999011175.SGD","IE00B19Z3B42.SGD","SG9999002224.SGD","LU1023059063.AUD","LU0868494617.USD","LU1894683348.USD","LU0321505868.SGD","BK4534"],"gpt_icon":1},{"id":"2581064332","title":"Protalix BioTherapeutics Inc. to Report Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2581064332","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581064332?lang=en_us&edition=fundamental","pubTime":"2025-11-06 19:50","pubTimestamp":1762429816,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protalix BioTherapeutics Inc. published the original content used to generate this news brief via PR Newswire  on November 06, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDLbd13VP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLX"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":40,"code":"91000000","status":"200"}]}}